The Laryngoscope · 2013 · 52 citations · 20 references
MedicineOtolaryngologySpeech-language PathologyLaryngologyOtolaryngologic SurgeryRhinologyBenign Vocal Fold LesionsLaryngeal StroboscopyLaryngeal SurgeryVoice RehabilitationVoice SurgeryAssessment Of PhonationEndoscopic Injection TherapyIntralesional Steroid TherapySelf-reported Voice HandicapTreatment Outcome AnalysisVocal Fold InjectionVocal Fold Mass LesionsVoice Handicap Index
OBJECTIVES/HYPOTHESIS: Emerging literature has documented the effectiveness of intralesional steroid injection as an alternative treatment for benign vocal fold disorders. However, clinical application is frequently limited by the associated technical demands for adequate anesthesia and precise needle placement. This study investigated the applicability and effectiveness of the more practical and less technically demanding method of transnasal endoscopic steroid injection (TESI). STUDY DESIGN: Prospective case series. METHODS: This study recruited 30 patients with vocal nodules and polyps. Dexamethasone was injected into the Reinke's space under local anesthesia via the operating channel of a transnasal flexible laryngoscope in an office setting. Treatment outcome were measured before, 1 month after, and 3 months after the injection, using videolaryngostroboscopy (VLS), maximal phonation time (MPT), 10-item voice handicap index (VHI-10), acoustic analysis, and perceptual evaluation. RESULTS: VLS examinations at 3 months post-treatment demonstrated that vocal lesions of 10 and 19 patients were resolved or reduced, respectively. Objective measurements showed increased MPT and decreased VHI-10 (P < .05 and P < .01, respectively). Acoustic analysis revealed significant decrease in jitter and shimmer (P < .05). Perceptual evaluation using the GRB (grade, roughness, breathiness) scale also showed improved voice quality (P < .01). Treatment outcomes were similar between vocal nodules and polyps (P > .05). Mild vocal hematoma occurred in three patients following TESI, but resolved spontaneously within 1 month. CONCLUSIONS: TESI is a simple and practical office-based treatment modality for benign vocal fold lesions, suitable for most otolaryngologists. Treatment outcomes showed significant subjective and objective improvements that were comparable to the results of other injection procedures reported in the literature. LEVEL OF EVIDENCE: 4.
20
Development and Validation of the Voice Handicap Index‐10
Clark A. Rosen, Annie S. Lee, Jamie Osborne et al. · The Laryngoscope · 2004 · 1.3K citations
Medicine, Speech-language Pathology, Communication Disorders +14
Clinical Practice Guideline: Hoarseness (Dysphonia)
Seth Schwartz, Seth M. Cohen, Seth H. Dailey et al. · Otolaryngology · 2009 · 447 citations
Vocal Fold Scarring: Current Concepts and Management
Michael S. Benninger, David M. Alessi, Sanford M. Archer et al. · Otolaryngology · 1996 · 271 citations
Office Steroid Injections of the Larynx
Melissa Mortensen, Peak Woo · The Laryngoscope · 2006 · 157 citations